Replies to post #10111 on Sorrento Therapeutics Inc (SRNE)

[1776club]

Well 2022 has a lot of P2 trials finishing in January through March (5) and another 5 that could be in P3 by February.
I expect there will be cash flow from EUA before then; diagnostics and ABIVERTINIB.
COVI-DROPS and COVI-MSC-(8,000 doses a month...hope they can do more than that) which has interest from WH, NIH has an interest in ANP, ANP has a relationship with the US Military and DARPA has an interest in VacciBody.
With a little push by India, Brazil, Mexico and the UK if trials show early success can bring it home quicker.
If you put lines on a mirror or pins on a board there are a lot of entities that have arrows going to SORRENTO...a lot.
Do not hear much about ANP but it will come.